Tag: cancer
May 22, 2018
5 Top Weekly NASDAQ Biotech Stocks: Eiger BioPharmaceuticals Leads with 81.62 Percent
Eiger BioPharmaceuticals, Arqule, Galectin Therapeutics, MEI Pharma and BioDelivery Sciences were last week's top gainers on the NASDAQ.
May 20, 2018
Cannabis Weekly Round-Up: Aurora Wants to Buy MedReleaf for C$3.2 Billion
The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the... May 13, 2018
5 Top Weekly NASDAQ Biotech Stocks: Helius Up 43.19 Percent
Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ. May 10, 2018
Aptevo Therapeutics Reports First Quarter 2018 Financial Results
Aptevo Therapeutics (Nasdaq:APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, today provided a business review and... May 10, 2018
MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) in Glioblastoma
MediciNova a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange... May 10, 2018
BeiGene Reports First Quarter 2018 Financial Results
BeiGene (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment... May 10, 2018
Cellectar Granted Orphan Drug Designation for CLR 131 to Treat Rhabdomyosarcoma
Cellectar Biosciences (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of...
May 10, 2018
3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma
3D Signatures Inc. (TSXV:DXD,OTCQB:TDSGF), a personalized medicine company with a proprietary software platform (TeloViewTM) based on the three-dimensional analysis of... May 9, 2018
argenx reports first quarter 2018 financial results and provides business update
argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment... May 9, 2018
